Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Guidnce

Allscripts (NASDAQ: MDRX) reported Q4 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $429.4 million versus the consensus estimate of $424.11 million.

2017 Financial Outlook

Allscripts affirms the following financial outlook for 2017, published originally on January 9, 2017:

• Non-GAAP revenue of between $1.71 billion and $1.74 billion;
• Adjusted EBITDA of between $345 million and $365 million, consisting of:
• Allscripts, excluding Netsmart, Adjusted EBITDA between $255-265 million, and;
• Netsmart Adjusted EBITDA between $90-100 million
• Non-GAAP earnings per share growth of between 10 to 15 percent

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
• Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance